British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen–ultraviolet A therapy 2015

2016/01/01 by T.C. Ling, Tsui C. Ling, Timothy Clayton +44 · 17 citations
Immunology and Microbiology · Medicine · Veterinary · #Psoriasis: Treatment and Pathogenesis #Skin Protection and Aging #Infectious Diseases and Mycology

paper · pdf · doi:10.1111/bjd.14317

Abstract

the quality of evidence and making the appropriate recommendations. When considered helpful to assist with comparing study results and to summarize data, forest plots drawn in Excel (Microsoft, Redmond, WA, U.S.A.) were used, 3 although no formal meta-analyses were performed to prepare this guideline. All subsections were subsequently collated and edited to produce the final guideline.

Cited by

• Depth Penetration of Light into Skin as a Function of Wavelength from 200 to 1000 nm
• A Perspective on the Use of NB-UVB Phototherapy vs. PUVA Photochemotherapy. [europepmc]
• From Early Immunomodulatory Triggers to Immunosuppressive Outcome: Therapeutic Implications of the Complex Interplay Between the Wavebands of Sunlight and the Skin. [europepmc]
• Polymorphic Light Eruption: What's New in Pathogenesis and Management. [europepmc]
• The Antipruritic Effect of Phototherapy. [europepmc]
• Comparison of Narrowband UV-B With Psoralen-UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides: A Systematic Review and Meta-analysis. [europepmc]
• Evaluation of Low-Dose, Low-Frequency Oral Psoralen-UV-A Treatment With or Without Maintenance on Early-Stage Mycosis Fungoides: A Randomized Clinical Trial. [europepmc]
• The European TREatment of ATopic eczema (TREAT) Registry Taskforce survey: prescribing practices in Europe for phototherapy and systemic therapy in adult patients with moderate-to-severe atopic eczema. [europepmc]
• Quality of Life, Anxiety, and Depression in Patients With Early-Stage Mycosis Fungoides and the Effect of Oral Psoralen Plus UV-A (PUVA) Photochemotherapy on it. [europepmc]
• Tracing the Photoaddition of Pharmaceutical Psoralens to DNA. [europepmc]
• Psoriasis: a brief overview. [europepmc]
• TaaI /Cdx-2 AA Variant of VDR Defines the Response to Phototherapy amongst Patients with Psoriasis. [europepmc]
• Comparison of ALitretinoin with PUVA as the first-line treatment in patients with severe chronic HAnd eczema (ALPHA): study protocol for a randomised controlled trial. [europepmc]
• Challenges in the Heterologous Production of Furanocoumarins in Escherichia coli . [europepmc]
• Suggested Guidelines for the Treatment of Mycosis Fungoides in Countries with Limited Resources. [europepmc]
• Nanoformulation of pomegranate peel extract enhances anti-psoriatic efficacy in a rat model. [europepmc]
• Biological Treatment of Psoriasis—Data So Far [europepmc]

Related

• Prevalence and Treatment of Psoriasis in the United Kingdom
• Methodological issues in visible LED therapy dermatological research and reporting
• British Association of Dermatologists living guideline for managing people with alopecia areata 2024
• Toward Harmonized Recommendations for Psoriatic Arthritis: A Comparative Viewpoint on Global Guidelines
• The Validity and Practicality of Sun-Reactive Skin Types I Through VI